# Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors

> **NCT01988896** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 153 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** Atezolizumab
- **DRUG:** Cobimetinib

## Key facts

- **NCT ID:** NCT01988896
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-27
- **Primary completion:** 2019-11-04
- **Final completion:** 2019-11-04
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01988896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01988896, "Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01988896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*